Cardiovascular

The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment.

Targets for Cardiovascular

Products for Cardiovascular

Cat.No. 상품명 정보
GC48229 Urotensin II (goby) (trifluoroacetate salt) A peptide vasoconstrictor
GC49777 Valsartan Acid A valsartan transformation product
GC48243 Vardenafil-d5 An internal standard for the quantification of vardenafil
GP10091 Vasonatrin Peptide (1-27) Vasonatrin Peptide (1-27), (C124H198N36O36S3), a peptide with the sequence H2N-GLSKGCFGLKLDRIGSMSGLGCNSFRY-OH, MW= 2865.4.
GC52150 Velaresol
GC49168 Visnagin 항산화제인 푸라노쿠마린 유도체인 Visnagin은 항염증 및 진통 특성을 가지고 있습니다.
GC45148 Vitamin K1 2,3-epoxide Vitamin K is a dietary nutrient essential for the normal biosynthesis of factors that are required for blood clotting.
GC46235 Vitamin K1-d7 An internal standard for the quantification of vitamin K₁
GC52180 WAY-169916 WAY-169916은 NF-kB 전사 활성을 억제하여 작용하는 ER(에스트로겐 수용체)의 경로 선택적 리간드입니다.
GC52084 YSK05 YSK05는 pH에 민감한 양이온성 지질입니다. YSK05는 비바이러스 벡터의 세포 내 트래피킹을 개선합니다. YSK05-MEND는 상당히 좋은 유전자 억제 활성과 용혈 활성을 나타냅니다. YSK05는 PEG화에 의한 엔도솜 탈출 억제를 극복합니다. YSK05는 시험관 내 및 생체 내 모두에서 siRNA 전달을 효과적으로 향상시킵니다.
GC52388 [D-Lys3]-GHRP-6 (trifluoroacetate salt) An antagonist of GHS-R1a
GC49484 [D-Trp8]-γ-MSH (trifluoroacetate salt) An MC3R agonist